Publication Date

8-1-2023

Journal

Redox Biology

DOI

10.1016/j.redox.2023.102790

PMID

37348155

PMCID

PMC10271936

PubMedCentral® Posted Date

6-16-2023

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

Humans, Infant, Newborn, Animals, Mice, Hyperoxia, Cytochrome P-450 CYP1A2, Lung Injury, Cytochrome P-450 CYP1A1, Mice, Inbred C57BL, COVID-19, Oxygen, Bronchopulmonary Dysplasia, Mice, Knockout, Lung, Animals, Newborn, Hyperoxia, Cytochrome P450, CYP1B1, Bronchopulmonary dysplasia, Lung, Oxidative stress

Abstract

Oxygen supplementation is life saving for premature infants and for COVID-19 patients but can induce long-term pulmonary injury by triggering inflammation, with xenobiotic-metabolizing CYP enzymes playing a critical role. Murine studies showed that CYP1B1 enhances, while CYP1A1 and CYP1A2 protect from, hyperoxic lung injury. In this study we tested the hypothesis that Cyp1b1-null mice would revert hyperoxia-induced transcriptomic changes observed in WT mice at the transcript and pathway level. Wild type (WT) C57BL/6J and Cyp1b1-null mice aged 8-10 weeks were maintained in room air (21% O

ga1.jpg (240 kB)
Graphical Abstract

Comments

Associated Data

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.